Allocations
The latest CEPRES Private Capital Market Outlook shows how Q2 2020 M&A deal value in the US declined by 60 per cent quarter-on-quarter which also represents a 50 per cent decrease year-on-year. These developments in the US exit markets reflect the weak market and investor sentiment during Q2, most likely impacted by the coronavirus pandemic.
Comparing to the last crisis, post-GFC private markets deal level median gross DPI (Distributions to Paid-in) recovered sharply to a 1.50x median DPI in 2009 compared to those deals with investment years between 2006 and 2008. This is followed by a softening of deal level
Restream, a multi-platform live streaming solution, has raised USD50 million in Series A financing led by Sapphire Ventures and Insight Partners. In addition, Restream is launching Restream Studio, a broadcasting production centre that makes live streaming across social platforms as easy as hosting a Zoom call. Restream will use the new capital to expand the company’s product offerings and continue to grow its global footprint, following 300 percent growth since January. Paul Levine, Managing Director at Sapphire Ventures, and Teddie Wardi, Managing Director at Insight Partners, will also join Restream’s board of directors.
Restream Studio enables businesses to broadcast live content
Unicorn VC deal value grew to EUR3.1 billion in H1 2020, and is on pace to surpass the EUR5.7 billion record set in 2019, according to PitchBook’s latest VC report, as companies like Deliveroo and N26 both closed substantial rounds in the first six months of the year.
UK private equity manager Maven Capital Partners (Maven) has invested GBP1.5 million in Gen inCode, a genetic testing business specialising in the risk assessment and prediction of cardiovascular disease.
Gen inCode raised in total GBP3.4 million, where Maven invested alongside another institutional investor and existing private shareholders.
Gen inCode has developed a range of patented DNA risk assessment products which utilise AI, bioinformatics and a globally recognised clinical evidence base to provide predictive analysis of a patient’s health risk. Proprietary algorithms are used to predict the probability of adverse events, resulting in a comprehensive risk evaluation that provides key insights
MidOcean Partners, a middle market private equity firm focused on the business services and consumer sectors, has acquired Music Reports, an independent provider of music rights data, administration, and management services, from ABRY Partners and the company’s co-founders, Ronald Gertz and Douglas Brainin. MidOcean’s investment will be used to accelerate Music Reports’ growth, both through organic product initiatives, as well as potential acquisitions. Financial terms of the transaction have not been disclosed.
Music Reports leverages its proprietary and continuously updated music and cue sheet databases, Songdex and Cuetrak, to deliver a full technology-enabled platform of advanced rights, payments, and royalty solutions
Private investment firm GI Partners has completed the previously announced acquisition of Clinical Ink, a global clinical trial technology company.Headquartered in Horsham, Pennsylvania, Clinical Ink offers data certainty from source to submission during clinical trials. The company’s Lumenis eSource clinical technology is a suite of solutions for capturing and integrating clinical trial electronic study data from sites, clinicians, and patients in real time. Through configurable direct data capture (DDC), electronic clinical outcome assessment (eCOA), electronic patient reported outcomes (ePRO), and eConsent modules, the company’s eSource Ecosystem has been deployed across 300 studies, in all Phases (I–IV).
In partnership with
kSARIA Corporation (kSARIA), a producer and supplier of mission-critical connectivity solutions for the aerospace and defence end markets and a portfolio company of Behrman Capital, has acquired Compulink Cable Assemblies (Compulink). Financial terms of the transaction have not been disclosed.Headquartered in St Petersburg, Florida, Compulink is an AS9100-registered manufacturer of high-reliability cables and harnesses for commercial and military applications. Since 1984, Compulink has served original equipment manufacturers nationwide with excellence in design engineering, prototype fabrication, production, and testing. The Company’s product capabilities include an array of harness assemblies such as coax, RF, Mil-C-38999 and miniaturised connectors, as well as custom-moulded
Phosplatin Therapeutics, a clinical stage pharmaceutical company focused on oncology therapeutics, has completed an oversubscribed USD18.4 million private financing round. Participation included new and existing investors, inclusive of family offices from the US, Europe and Asia-Pacific, and high net worth individuals.
Robert Fallon, President and Chief Executive Officer of Phosplatin Therapeutics, says: “The success of the financing underscores the breadth of our data from three different Phase I trials and the broad potential of our lead compound, PT-112, which is advancing through clinical development as a monotherapy, including in mCRPC and multiple myeloma, and in combination with PD-L1 immune checkpoint inhibition.
Texas-based private investment firm Andros Capital Partners closed its energy-focused inaugural investment fund Andros Energy Capital at its USD250 million hard cap last week. Private Equity Wire caught up with founder Phillip A Gayle JR (pictured) to find out about current developments within the energy sector, where the opportunities are and his thoughts on the new normal.
Apex Group (Apex), a global financial services provider, has been appointed to provide full fund administration services to Preservation Capital Partners (Preservation Capital).Fund administration is at the core of Apex’s offering, providing clients with timely, accurate and independent portfolio administration using innovative technology and highly qualified personnel with local expertise.
Preservation Capital, a specialist investor in the asset-light financial services sector, last month announced the closing of its debut fund, Preservation Capital Partners Fund I at its hard cap of GBP309 million (USD400 million).
Apex’s fully integrated global fund administration system and high-speed, real-time processing enables the delivery
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
